Prescient Therapeutics Limited (PTX.AX)
AUD 0.04
(0.0%)
AUD 0.04
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -8.23 Million AUD | -17.61% |
| 2023 | -7 Million AUD | -36.88% |
| 2022 | -5.11 Million AUD | -23.34% |
| 2021 | -4.14 Million AUD | -24.92% |
| 2020 | -3.32 Million AUD | 12.54% |
| 2019 | -3.79 Million AUD | -47.54% |
| 2018 | -2.57 Million AUD | -0.24% |
| 2017 | -2.56 Million AUD | -46.38% |
| 2016 | -1.75 Million AUD | 17.78% |
| 2015 | -2.13 Million AUD | -64.5% |
| 2014 | -1.29 Million AUD | -172.57% |
| 2013 | 1.78 Million AUD | 194.43% |
| 2012 | -1.89 Million AUD | -38.94% |
| 2011 | -1.36 Million AUD | 26.93% |
| 2010 | -1.86 Million AUD | -38.48% |
| 2009 | -1.34 Million AUD | 24.08% |
| 2008 | -1.77 Million AUD | 33.52% |
| 2007 | -2.66 Million AUD | 42.34% |
| 2006 | -4.62 Million AUD | -15.65% |
| 2005 | -3.99 Million AUD | 0.72% |
| 2004 | -4.02 Million AUD | -31.16% |
| 2003 | -3.07 Million AUD | -15.97% |
| 2002 | -2.64 Million AUD | -15.48% |
| 2001 | -2.29 Million AUD | 5.21% |
| 2000 | -2.41 Million AUD | -69.75% |
| 1999 | -1.42 Million AUD | -38.22% |
| 1998 | -1.03 Million AUD | 21.12% |
| 1997 | -1.3 Million AUD | 0.0% |
| 1996 | - AUD | 100.0% |
| 1995 | -8000.00 AUD | 60.0% |
| 1994 | -20 Thousand AUD | 13.04% |
| 1993 | -23 Thousand AUD | -9.52% |
| 1992 | -21 Thousand AUD | 90.45% |
| 1991 | -220 Thousand AUD | -210.0% |
| 1990 | 200 Thousand AUD | 317.39% |
| 1989 | -92 Thousand AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 FY | -8.23 Million AUD | -17.61% |
| 2024 Q4 | -4.61 Million AUD | 0.0% |
| 2024 Q2 | -3.61 Million AUD | 0.0% |
| 2023 Q2 | -2.87 Million AUD | 0.0% |
| 2023 FY | -7 Million AUD | -36.88% |
| 2023 Q4 | -4.12 Million AUD | 0.0% |
| 2022 FY | -5.11 Million AUD | -23.34% |
| 2022 Q4 | -2.5 Million AUD | 0.0% |
| 2022 Q2 | -2.61 Million AUD | 0.0% |
| 2021 Q4 | -2.35 Million AUD | 0.0% |
| 2021 FY | -4.14 Million AUD | -24.92% |
| 2021 Q2 | -1.79 Million AUD | 0.0% |
| 2020 Q4 | -1.62 Million AUD | 0.0% |
| 2020 FY | -3.32 Million AUD | 12.54% |
| 2020 Q2 | -1.69 Million AUD | 0.0% |
| 2019 FY | -3.79 Million AUD | -47.54% |
| 2019 Q4 | -2.2 Million AUD | 0.0% |
| 2019 Q2 | -1.59 Million AUD | 0.0% |
| 2018 Q2 | -1.18 Million AUD | 0.0% |
| 2018 Q4 | -1.39 Million AUD | 0.0% |
| 2018 FY | -2.57 Million AUD | -0.24% |
| 2017 Q4 | -1.54 Million AUD | 0.0% |
| 2017 FY | -2.56 Million AUD | -46.38% |
| 2017 Q2 | -1.02 Million AUD | 0.0% |
| 2016 Q4 | -1.13 Million AUD | 0.0% |
| 2016 Q2 | -622.67 Thousand AUD | 0.0% |
| 2016 FY | -1.75 Million AUD | 17.78% |
| 2015 Q4 | -1.07 Million AUD | 0.0% |
| 2015 FY | -2.13 Million AUD | -64.5% |
| 2015 Q2 | -1.06 Million AUD | 0.0% |
| 2014 Q4 | -583.39 Thousand AUD | 0.0% |
| 2014 Q2 | -1.18 Million AUD | 0.0% |
| 2014 FY | -1.29 Million AUD | -172.57% |
| 2013 Q4 | 446.75 Thousand AUD | 0.0% |
| 2013 Q3 | 446.75 Thousand AUD | -75.0% |
| 2013 FY | 1.78 Million AUD | 194.43% |
| 2013 Q2 | 1.78 Million AUD | 477.73% |
| 2013 Q1 | -473.09 Thousand AUD | 0.0% |
| 2012 Q1 | -340.39 Thousand AUD | 0.0% |
| 2012 FY | -1.89 Million AUD | -38.94% |
| 2012 Q4 | -473.09 Thousand AUD | 0.0% |
| 2012 Q3 | -473.09 Thousand AUD | 0.0% |
| 2012 Q2 | -473.09 Thousand AUD | -38.98% |
| 2011 Q4 | -340.39 Thousand AUD | 0.0% |
| 2011 Q3 | -340.39 Thousand AUD | 0.0% |
| 2011 Q2 | -340.39 Thousand AUD | 26.96% |
| 2011 Q1 | -466.06 Thousand AUD | 0.0% |
| 2011 FY | -1.36 Million AUD | 26.93% |
| 2010 Q1 | -336.48 Thousand AUD | 0.0% |
| 2010 Q4 | -466.06 Thousand AUD | 0.0% |
| 2010 FY | -1.86 Million AUD | -38.48% |
| 2010 Q3 | -466.06 Thousand AUD | 0.0% |
| 2010 Q2 | -466.06 Thousand AUD | -38.51% |
| 2009 Q2 | -336.48 Thousand AUD | 24.11% |
| 2009 Q4 | -336.48 Thousand AUD | 0.0% |
| 2009 Q1 | -443.36 Thousand AUD | 0.0% |
| 2009 FY | -1.34 Million AUD | 24.08% |
| 2009 Q3 | -336.48 Thousand AUD | 0.0% |
| 2008 Q4 | -443.36 Thousand AUD | 0.0% |
| 2008 Q1 | -666.83 Thousand AUD | 0.0% |
| 2008 FY | -1.77 Million AUD | 33.52% |
| 2008 Q2 | -443.36 Thousand AUD | 33.51% |
| 2008 Q3 | -443.36 Thousand AUD | 0.0% |
| 2007 Q1 | -1.15 Million AUD | 0.0% |
| 2007 Q3 | -666.83 Thousand AUD | 0.0% |
| 2007 FY | -2.66 Million AUD | 42.34% |
| 2007 Q4 | -666.83 Thousand AUD | 0.0% |
| 2007 Q2 | -666.83 Thousand AUD | 42.33% |
| 2006 FY | -4.62 Million AUD | -15.65% |
| 2006 Q2 | -1.15 Million AUD | -15.67% |
| 2006 Q3 | -1.15 Million AUD | 0.0% |
| 2006 Q1 | -999.7 Thousand AUD | 0.0% |
| 2006 Q4 | -1.15 Million AUD | 0.0% |
| 2005 FY | -3.99 Million AUD | 0.72% |
| 2005 Q1 | -990.86 Thousand AUD | 0.0% |
| 2005 Q4 | -999.7 Thousand AUD | 0.0% |
| 2005 Q3 | -999.7 Thousand AUD | 0.0% |
| 2005 Q2 | -999.7 Thousand AUD | -0.89% |
| 2004 Q3 | -990.86 Thousand AUD | 0.0% |
| 2004 Q2 | -990.86 Thousand AUD | -26.41% |
| 2004 FY | -4.02 Million AUD | -31.16% |
| 2004 Q1 | -783.82 Thousand AUD | 0.0% |
| 2004 Q4 | -990.86 Thousand AUD | 0.0% |
| 2003 FY | -3.07 Million AUD | -15.97% |
| 2003 Q3 | -783.82 Thousand AUD | 0.0% |
| 2003 Q4 | -783.82 Thousand AUD | 0.0% |
| 2003 Q2 | -783.82 Thousand AUD | -18.42% |
| 2003 Q1 | -661.87 Thousand AUD | 0.0% |
| 2002 Q2 | -661.87 Thousand AUD | -15.45% |
| 2002 Q3 | -661.87 Thousand AUD | 0.0% |
| 2002 Q4 | -661.87 Thousand AUD | 0.0% |
| 2002 FY | -2.64 Million AUD | -15.48% |
| 2002 Q1 | -573.3 Thousand AUD | 0.0% |
| 2001 Q2 | -573.3 Thousand AUD | -0.48% |
| 2001 FY | -2.29 Million AUD | 5.21% |
| 2001 Q4 | -573.3 Thousand AUD | 0.0% |
| 2001 Q1 | -570.57 Thousand AUD | 0.0% |
| 2001 Q3 | -573.3 Thousand AUD | 0.0% |
| 2000 Q3 | -570.57 Thousand AUD | 0.0% |
| 2000 FY | -2.41 Million AUD | -69.75% |
| 2000 Q1 | -356.24 Thousand AUD | 0.0% |
| 2000 Q2 | -570.57 Thousand AUD | -60.16% |
| 2000 Q4 | -570.57 Thousand AUD | 0.0% |
| 1999 FY | -1.42 Million AUD | -38.22% |
| 1999 Q1 | - AUD | 0.0% |
| 1999 Q2 | -356.24 Thousand AUD | 0.0% |
| 1999 Q4 | -356.24 Thousand AUD | 0.0% |
| 1999 Q3 | -356.24 Thousand AUD | 0.0% |
| 1998 FY | -1.03 Million AUD | 21.12% |
| 1998 Q4 | - AUD | 0.0% |
| 1998 Q3 | - AUD | 0.0% |
| 1998 Q2 | - AUD | 0.0% |
| 1998 Q1 | - AUD | 0.0% |
| 1997 Q2 | - AUD | 0.0% |
| 1997 FY | -1.3 Million AUD | 0.0% |
| 1997 Q3 | - AUD | 0.0% |
| 1997 Q1 | - AUD | 0.0% |
| 1997 Q4 | - AUD | 0.0% |
| 1996 FY | - AUD | 100.0% |
| 1996 Q4 | - AUD | 0.0% |
| 1996 Q3 | - AUD | 0.0% |
| 1996 Q2 | - AUD | 0.0% |
| 1996 Q1 | - AUD | 0.0% |
| 1995 FY | -8000.00 AUD | 60.0% |
| 1995 Q4 | - AUD | 0.0% |
| 1995 Q3 | - AUD | 0.0% |
| 1995 Q2 | - AUD | 0.0% |
| 1995 Q1 | - AUD | 0.0% |
| 1994 Q1 | - AUD | 0.0% |
| 1994 FY | -20 Thousand AUD | 13.04% |
| 1994 Q4 | - AUD | 0.0% |
| 1994 Q3 | - AUD | 0.0% |
| 1994 Q2 | - AUD | 0.0% |
| 1993 Q3 | - AUD | 0.0% |
| 1993 Q2 | - AUD | 100.0% |
| 1993 Q1 | -5250.00 AUD | 0.0% |
| 1993 Q4 | - AUD | 0.0% |
| 1993 FY | -23 Thousand AUD | -9.52% |
| 1992 Q3 | -5250.00 AUD | 0.0% |
| 1992 Q4 | -5250.00 AUD | 0.0% |
| 1992 FY | -21 Thousand AUD | 90.45% |
| 1992 Q1 | -55 Thousand AUD | 0.0% |
| 1992 Q2 | -5250.00 AUD | 90.45% |
| 1991 Q4 | -55 Thousand AUD | 0.0% |
| 1991 Q3 | -55 Thousand AUD | 0.0% |
| 1991 FY | -220 Thousand AUD | -210.0% |
| 1991 Q2 | -55 Thousand AUD | -210.0% |
| 1991 Q1 | 50 Thousand AUD | 0.0% |
| 1990 Q2 | 50 Thousand AUD | 317.39% |
| 1990 Q4 | 50 Thousand AUD | 0.0% |
| 1990 Q3 | 50 Thousand AUD | 0.0% |
| 1990 Q1 | -23 Thousand AUD | 0.0% |
| 1990 FY | 200 Thousand AUD | 317.39% |
| 1989 Q3 | -23 Thousand AUD | 0.0% |
| 1989 FY | -92 Thousand AUD | 0.0% |
| 1989 Q4 | -23 Thousand AUD | 0.0% |
| 1989 Q2 | -23 Thousand AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 6.96 Million AUD | 218.286% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -467.655% |
| Zelira Therapeutics Limited | -36.56 Million AUD | 77.473% |
| Biome Australia Limited | -1.67 Million AUD | -393.237% |
| Patrys Limited | -3.53 Million AUD | -132.769% |
| Orthocell Limited | -7.18 Million AUD | -14.721% |
| Imugene Limited | -149.68 Million AUD | 94.496% |
| Noxopharm Limited | -3.57 Million AUD | -130.234% |
| PYC Therapeutics Limited | -37.72 Million AUD | 78.163% |
| Chimeric Therapeutics Limited | -12.52 Million AUD | 34.253% |
| Proteomics International Laboratories Limited | -6.37 Million AUD | -29.2% |
| Cynata Therapeutics Limited | -9.74 Million AUD | 15.461% |
| CSL Limited | 2.64 Billion AUD | 100.312% |
| Arovella Therapeutics Limited | -8.74 Million AUD | 5.808% |
| Bio-Gene Technology Limited | -2.4 Million AUD | -241.944% |
| Clinuvel Pharmaceuticals Limited | 35.63 Million AUD | 123.117% |
| Starpharma Holdings Limited | -8.16 Million AUD | -0.895% |
| Nanollose Limited | -1.15 Million AUD | -612.293% |
| Memphasys Limited | -4.44 Million AUD | -85.457% |
| Invex Therapeutics Ltd | -1.64 Million AUD | -401.767% |
| NeuroScientific Biopharmaceuticals Limited | 324.21 Thousand AUD | 2640.961% |
| Amplia Therapeutics Limited | -4.5 Million AUD | -82.927% |
| Botanix Pharmaceuticals Limited | -13.86 Million AUD | 40.604% |
| Island Pharmaceuticals Limited | -2.86 Million AUD | -187.609% |
| Race Oncology Limited | -13.81 Million AUD | 40.388% |
| Nyrada Inc. | -1.38 Million AUD | -494.278% |
| Telix Pharmaceuticals Limited | 5.21 Million AUD | 258.09% |
| Dimerix Limited | -17.07 Million AUD | 51.754% |
| PharmAust Limited | -9.03 Million AUD | 8.794% |
| Immutep Limited | -39.89 Million AUD | 79.351% |
| Clarity Pharmaceuticals Ltd | -42.32 Million AUD | 80.536% |
| Alterity Therapeutics Limited | -19.12 Million AUD | 56.922% |
| BTC Health Limited | 1.05 Million AUD | 880.645% |
| Acrux Limited | -5.8 Million AUD | -42.035% |
| Neuren Pharmaceuticals Limited | 157.08 Million AUD | 105.244% |
| Biotron Limited | -3.43 Million AUD | -139.72% |
| Tissue Repair Ltd | -4.13 Million AUD | -99.078% |
| AdAlta Limited | -5.38 Million AUD | -53.087% |
| Radiopharm Theranostics Limited | -47.94 Million AUD | 82.819% |
| Hexima Limited | -933.87 Thousand AUD | -782.138% |
| AnteoTech Limited | -8.88 Million AUD | 7.235% |
| Paradigm Biopharmaceuticals Limited | -58.65 Million AUD | 85.955% |
| Recce Pharmaceuticals Ltd | -17.66 Million AUD | 53.356% |
| Avecho Biotechnology Limited | -3.43 Million AUD | -139.718% |
| Actinogen Medical Limited | -13.04 Million AUD | 36.846% |
| Immuron Limited | -6.93 Million AUD | -18.756% |
| Argenica Therapeutics Limited | -5.47 Million AUD | -50.343% |